$4.83
0.183.87%
At close: -
$4.67
-0.16-3.31%
After Hours: Jan 17, 9:29 AM EDT
Mainz Biomed reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mainz Biomed using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
H1 | 2024-10-21 | $-19.60 | $-8.80 | -122.7 % |
Q4 | 2024-04-09 | $-9.60 | $-12.80 | 25.0 % |
Q3 | 2023-11-16 | $-15.60 | $-18.80 | 17.0 % |
Q2 | 2023-08-15 | $-22.40 | $-16.80 | -33.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
H1 | 2024-10-21 | $520.77K | $300.00K | 73.6 % |
Q4 | 2024-04-09 | $214.76K | $270.00K | -20.5 % |
Q3 | 2023-11-16 | $181.67K | $330.00K | -45.0 % |
FY | 2023-04-10 | $529.88K | $697.50K | -24.0 % |
Mainz Biomed (MYNZ) is scheduled to report earnings on April 15, 2025. The last reported earnings were for reported on October 21, 2024 for H1.
The Actual EPS was $-19.60, which missed the estimate of $-8.80.
The Actual Revenue was $520.8K, which beat the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.